Patrick A. Cunningham, the chief compliance officer of Aveanna Healthcare (AVAH 0.50%), directly sold 36,015 shares in multiple open-market transactions between Dec. 30 and Jan. 2, for a total value of $292,488, according to an SEC Form 4 filing.
Transaction Summary
| Metric | Value |
|---|---|
| Shares sold (direct) | 36,015 |
| Transaction value | $292,488 |
| Post-transaction shares (direct) | 293,354 |
| Post-transaction value (direct ownership) | $2.4 million |
The transaction value is based on the SEC Form 4 weighted average purchase price ($8.12), and the post-transaction value is based on Friday's market close ($8.12).
Key Questions
- How significant is this sale relative to previous insider activity?
This direct sale of 36,015 shares is the largest single open-market disposition by Cunningham in at least the past year, indicating a higher-than-typical volume for his sales activity. He only has one other sale on record, of 18,500 shares in June. - What proportion of direct ownership was affected by this transaction?
The sale accounted for 10.93% of Cunningham’s direct holdings, resulting in a reduction from 329,369 to 293,354 directly held shares. - Does the transaction involve any derivative instruments or indirect entities?
No; all shares were sold from direct holdings, with no participation from trusts, LLCs, or option-related activity -- reflecting a straightforward open-market disposition. - How does this transaction relate to remaining capacity and recent trading patterns?
Cunningham owns fewer shares than he did a year ago, so each sale now counts for more. That means the size of this latest sale likely reflects the smaller size of his remaining stake rather than a meaningful shift in his selling behavior.
Company Overview
| Metric | Value |
|---|---|
| Revenue (TTM) | $2.29 billion |
| Net income (TTM) | $75.46 million |
| Employees | 33,500 |
| 1-year price change | 99% |
Company Snapshot
- Aveanna Healthcare provides private duty nursing, adult home health and hospice, pediatric therapy, and enteral nutrition services, with revenue streams diversified across Private Duty Services, Home Health & Hospice, and Medical Solutions segments.
- The company operates a patient-centered, home-based care platform that generates revenue through direct care services and medical supply distribution, targeting cost-effective alternatives to institutional healthcare settings.
- It serves medically fragile children, adults requiring home health or hospice care, and patients needing ongoing nutritional support, primarily across the United States.
Aveanna Healthcare is a diversified U.S. provider of home-based clinical care and medical solutions, leveraging a workforce of 33,500 employees to deliver services to medically complex populations. The company’s integrated platform emphasizes cost efficiency and patient outcomes by prioritizing in-home care over higher-cost institutional alternatives.
What this transaction means for investors
For long-term investors, Cunningham’s recent stock sale matters less as a directional signal and more as a reminder of how insider mechanics intersect with a sharply improving business. Aveanna Healthcare is in the middle of a turnaround year: Third-quarter revenue jumped 22.2% year over year to $621.9 million, adjusted EBITDA surged 67.5% to $80.1 million, and management raised full-year guidance to more than $2.375 billion in revenue and $300 million in adjusted EBITDA. That operating momentum helps explain why AVAH shares are up roughly 99% over the past year, far outpacing the S&P 500’s 17% gain.
Against that backdrop, Cunningham, Aveanna’s chief compliance officer, sold 36,015 shares between Dec. 30 and Jan. 2 at a weighted average price of $8.12, for proceeds of about $292,000. Importantly, the Form 4 notes that the shares were automatically sold to satisfy tax obligations tied to vested equity awards -- not discretionary selling.
The sale reduced Cunningham’s direct holdings by about 11%, but context matters. He owns fewer shares than he did a year ago, meaning each transaction now represents a larger percentage of his stake. For investors, the durability of Aveanna’s margin expansion, cash generation, and raised outlook remains far more consequential than a capacity-driven insider sale.
Glossary
Open-market transaction: The purchase or sale of securities on a public exchange, not through private agreements.
Direct ownership: Shares held personally by an individual, not through trusts, funds, or other entities.
Indirect holdings: Shares owned via another entity, such as a trust or company, rather than directly by the individual.
Derivative instruments: Financial contracts whose value is based on the performance of underlying assets, like options or futures.
Disposition: The act of selling or otherwise transferring ownership of an asset.
Weighted average price: The average price of shares sold or bought, adjusted for the number of shares at each price.
SEC Form 4: A required filing that reports insider trades of a company’s securities by officers, directors, or major shareholders.
Capacity-driven: Refers to actions influenced by the remaining amount of shares or resources available for trading.
Median sell transaction: The middle value in a series of insider sales, used to compare transaction sizes.
TTM: The 12-month period ending with the most recent quarterly report.
Discretionary moderation: Voluntarily reducing the size or frequency of transactions, rather than acting out of necessity.
Disposition by open-market sale: Selling shares directly on the stock market, as opposed to private or negotiated sales.
